Staging ::: VER CORREOS
Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
6.378 / 17.039
#51019

Re: Farmas USA

Nvax

No. He dejado puesta orden de 2500, pero no ha entrado por ahora.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#51020

Re: Farmas USA

GALE

Las stock options deben ser para el nuevo director cuya designación acaban de anunciar en un 8k. Modo móvil

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#51021

Re: Farmas USA

http://www.streetinsider.com/Analyst+Comments/Wedbush+Assumes+Novavax+(NVAX)+at+Outperform/9845410.html

Wedbush initiated coverage on Novavax (NASDAQ: NVAX) with an Outperform rating and a price target of $10.00 (prior $12.00).

Analyst Heather Behanna said, "Novavax’s analyst day next week should provide clarity on timelines for a busy 2015. Novavax is gearing up for three trials for its RSV vaccine program by year end; it has begun a proof-of-concept study for maternal immunization and will initiate studies in both pediatric and elderly populations. A dose confirmation study of its retooled quadrivalent flu vaccine will also be initiated this year; all four studies should read out data in 2015, driving value for Novavax."

"We arrive at our price target applying a 5x multiple to RSV US peak sales in 2022 and a 15x multiple on royalties for ex-US RSV revenue and worldwide flu vaccine revenue in 2022, discounted by 25%. Our change in validation methodology and refinement of regulatory timelines accounts for our price target change," she added.

---------
Han restado el % equivalente al de la dilucion al PO diria yo (bueno, algo mas )

NVAX

#51024

Re: Farmas USA

framus, ya somos dos.:(

PPHM